The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Altered Myeloid Development and Acute Leukemia in Transgenic Mice Expressing PML-RARα Under Control of Cathepsin G Regulatory Sequences
Abstract
Acute promyelocytic leukemia (APML) is characterized by abnormal myeloid development, resulting an accumulation of leukemic promyelocytes that are often highly sensitive to retinoic acid. A balanced t(15; 17) (q22; q21) reciprocal chromosomal translocation is found in approximately 90% of APML patients; this translocation fuses the PML gene on chromosome 15 to the retinoic acid receptor α (RARα) gene on chromosome 17, creating two novel fusion genes, PML-RARα and RARα-PML. The PML-RARα fusion gene product, which is expressed in virtually all patients with t(15; 17), is thought to play a direct role in the pathogenesis of APML. To determine whether PML-RARα is sufficient to cause APML in an animal model, we used the promyelocyte-specific targeting sequences of the human cathepsin G (hCG) gene to direct the expression of a PML-RARα cDNA to the early myeloid cells of transgenic mice. Mice expressing the hCG–PML-RARα transgene were found to have altered myeloid development that was characterized by increased percentages of immature and mature myeloid cells in the peripheral blood, bone marrow, and spleen. In addition, approximately 30% of transgene-expressing mice eventually developed acute myeloid leukemia after a long latent period. The splenic promyelocytes of mice with both the nonleukemic and leukemic phenotypes responded to all-trans retinoic acid (ATRA) treatment, which caused apoptosis of myeloid precursors. Although low-level expression of the hCG–PML-RARα transgene is not sufficient to directly cause acute myeloid leukemia in mice, its expression alters myeloid development, resulting in an accumulation of myeloid precursors that may be susceptible to cooperative transforming events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
Huang, M., Ye, Y., Chen, Sr., Chai, Jr., Lu, J., Zhoa, L., Gu, L., & Wang, Z. (1988) · Blood · doi:10.1182/blood.v72.2.567.567 · Cited by 2,445
Kakizuka, A., Miller, W. H., Umesono, K., Warrell, R. P., Frankel, S. R., Murty, V. V. V. S., Dmitrovsky, E., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90112-c · Cited by 1,427
de Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355
de Thé, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L., & Dejean, A. (1991) · Cell · doi:10.1016/0092-8674(91)90113-d · Cited by 1,343
Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)
Warrell, R. P., Frankel, S. R., Miller, W. H., Scheinberg, D. A., Itri, L. M., Hittelman, W. N., Vyas, R., Andreeff, M., Tafuri, A., Jakubowski, A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105163242002 · Cited by 1,251
Castaigne, S., Chomienne, C., Daniel, M., Ballerini, P., Berger, R., Fenaux, P., & Degos, L. (1990) · Blood · doi:10.1182/blood.v76.9.1704.1704 · Cited by 1,184
All-trans-Retinoic Acid in Acute Promyelocytic Leukemia
Tallman, M. S., Andersen, J. W., Schiffer, C. A., Appelbaum, F. R., Feusner, J. H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C. D., Rowe, J. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371501 · Cited by 1,073
A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
Dyck, J. A., Maul, G. G., Miller, W. H., Chen, J. D., Kakizuka, A., & Evans, R. M. (1994) · Cell · doi:10.1016/0092-8674(94)90340-9 · Cited by 785
Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A., & Dejean, A. (1994) · Cell · doi:10.1016/0092-8674(94)90341-7 · Cited by 652
15/17 TRANSLOCATION, A CONSISTENT CHROMOSOMAL CHANGE IN ACUTE PROMYELOCYTIC LEUKAEMIA
Rowley, J., Golomb, H., & Dougherty, C. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91415-5 · Cited by 633
Grignani, F., Ferrucci, P. F., Testa, U., Talamo, G., Fagioli, M., Alcalay, M., Mencarelli, A., Grignani, F., Peschle, C., Nicoletti, I., et al. (1993) · Cell · doi:10.1016/0092-8674(93)80044-f · Cited by 583
Self-citationHigh postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice.
Lufkin, T., Lohnes, D., Mark, M., Dierich, A., Gorry, P., Gaub, M. P., LeMeur, M., & Chambon, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7225 · Cited by 545
The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion.
Koken, M. H., Puvion-Dutilleul, F., Guillemin, M. C., Viron, A., Linares-Cruz, G., Stuurman, N., de Jong, L., Szostecki, C., Calvo, F., & Chomienne, C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06356.x · Cited by 499
Characterization of a Zinc Finger Gene Disrupted by the t(15;17) in Acute Promyelocytic Leukemia
Goddard, A. D., Borrow, J., Freemont, P. S., & Solomon, E. (1991) · Science · doi:10.1126/science.1720570 · Cited by 458
Kastner, P., Perez, A., Lutz, Y., Rochette-Egly, C., Gaub, M. P., Durand, B., Lanotte, M., Berger, R., & Chambon, P. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05095.x · Cited by 415
MORTALITY IN ORAL CONTRACEPTIVE USERS
VESSEY, M. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92875-0 · Cited by 394
Chomienne, C., Ballerini, P., Balitrand, N., Daniel, M., Fenaux, P., Castaigne, S., & Degos, L. (1990) · Blood · doi:10.1182/blood.v76.9.1710.1710 · Cited by 375
Collins, S. J., Robertson, K. A., & Mueller, L. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.5.2154 · Cited by 318
Pandolfi, P. P., Grignani, F., Alcalay, M., Mencarelli, A., Biondi, A., Lo‐Coco, F., Grignani, F., & Pelicci, P. G. (1991) · PubMed · Cited by 305
Self-citationPMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR.
Perez, A., Kastner, P., Sethi, S., Lutz, Y., Reibel, C., & Chambon, P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05986.x · Cited by 292
PML, a growth suppressor disrupted in acute promyelocytic leukemia.
Mu, Z. M., Chin, K. V., Liu, J. H., Lozano, G., & Chang, K. S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6858 · Cited by 288
PML protein expression in hematopoietic and acute promyelocytic leukemia cells
Daniel, M., Koken, M., Romagne, O., Barbey, S., Bazarbachi, A., Stadler, M., Guillemin, M., Degos, L., Chomienne, C., & de The, H. (1993) · Blood · doi:10.1182/blood.v82.6.1858.1858 · Cited by 251
The PML growth-suppressor has an altered expression in human oncogenesis.
Koken, M. H. M., Linares‐Cruz, G., Quignon, F., Viron, A., Chelbi‐Alix, M. K., Sobczak‐Thépot, J., Juhlin, L., Degos, L., Calvo, F. M., & de Thé, H. (1995) · PubMed · Cited by 231
Tsai, S., & Collins, S. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7153 · Cited by 210
Li, E., Sucov, H. M., Lee, K. F., Evans, R. M., & Jaenisch, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1590 · Cited by 188
Expression pattern of the RAR alpha-PML fusion gene in acute promyelocytic leukemia.
Alcalay, M., Zangrilli, D., Fagioli, M., Pandolfi, P. P., Mencarelli, A., Coco, F. L., Biondi, A., Grignani, F., & Pelicci, P. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4840 · Cited by 147
Self-citationThe PML gene encodes a phosphoprotein associated with the nuclear matrix
Chang, K., Fan, Y., Andreeff, M., Liu, J., & Mu, Z. (1995) · Blood · doi:10.1182/blood.v85.12.3646.bloodjournal85123646 · Cited by 145
Turhan, A. G., Lemoine, F. M., Debert, C., Bonnet, M., Baillou, C., Picard, F., Macintyre, E. A., & Varet, B. R. (1995) · Blood · doi:10.1182/blood.v85.8.2154.bloodjournal8582154 · Cited by 128
McGuire, E. A., Rintoul, C. E., Sclar, G. M., & Korsmeyer, S. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.9.4186 · Cited by 119
Transgenic expression of PML/RARalpha impairs myelopoiesis.
Early, E., Moore, M. A., Kakizuka, A., Nason-Burchenal, K., Martin, P., Evans, R. M., & Dmitrovsky, E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7900 · Cited by 110
Dziennis, S., Etten, R. A. V., Pahl, H., Morris, D. L., Rothstein, T. L., Blosch, C., Perlmutter, R. M., & Tenen, D. G. (1995) · Blood · doi:10.1182/blood.v85.2.319.bloodjournal852319 · Cited by 103
Flenghi, L., Fagioli, M., Tomassoni, L., Pileri, S. A., Gambacorta, M., Pacini, R., Grignani, F., Casini, T., Ferrucci, P. F., Martelli, M., et al. (1995) · Blood · doi:10.1182/blood.v85.7.1871.bloodjournal8571871 · Cited by 102
Self-citationRousselot, P. H., Hardas, B., Patel, A. B., Guidez, F., Gäken, J. A., Castaigné, S., Dejean, A., de Thé, H., Degos, L., & Farzaneh, F. (1994) · PubMed · Cited by 101
Jansen, J. H., Mahfoudi, A., Rambaud, S., Lavau, C., Wahli, W., & Dejean, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7401 · Cited by 86
Chang, K. S., Stass, S. A., Chu, D. T. W., Deaven, L. L., Trujillo, J. M., & Freireich, E. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.2.800 · Cited by 78
Tissue-specific expression and developmental regulation of the human fgr proto-oncogene.
Ley, T. J., Connolly, N. L., Katamine, S., Cheah, M. S., Senior, R. M., & Robbins, K. C. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.1.92 · Cited by 73
Self-citationAcute promyelocytic leukemia cases with nonreciprocal PML/RARa or RARa/PML fusion genes
Lafage‐Pochitaloff, M., Alcalay, M., Brunel, V., Longo, L., Sainty, D., Simonetti, J., Birg, F., & Pelicci, P. G. (1995) · Blood · doi:10.1182/blood.v85.5.1169.1169 · Cited by 66
Self-citationSkalnik, D. G., Dorfman, D. M., Perkins, A. S., Jenkins, N. A., Copeland, N. G., & Orkin, S. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8505 · Cited by 53
Early myeloid cell-specific expression of the human cathepsin G gene in transgenic mice.
Grisolano, J. L., Sclar, G. M., & Ley, T. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8989 · Cited by 53
Self-citationDawson, M., Elstner, E., Kizaki, M., Chen, D., Pakkala, S., Kerner, B., & Koeffler, H. (1994) · Blood · doi:10.1182/blood.v84.2.446.446 · Cited by 49
Back, A. L., East, K., & Hickstein, D. D. (1995) · Blood · doi:10.1182/blood.v85.4.1017.bloodjournal8541017 · Cited by 21
Paggi, M. G., de Fabritiis, P., Bonetto, F., Amadio, L., Santarelli, G., Spadea, A., Fp, G., Floridi, A., & Felsani, A. (1995) · PubMed · Cited by 14
Cited by
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1779 · Cited by 2,200
Self-citationMelnick, A., & Licht, J. D. (1999) · Blood · doi:10.1182/blood.v93.10.3167.410k44_3167_3215 · Cited by 1,028
The role of FLT3 in haematopoietic malignancies
Stirewalt, D. L., & Radich, J. P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1169 · Cited by 865
Transcription Factors, Normal Myeloid Development, and Leukemia
Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735
He, L.-Z., Guidez, F., Tribioli, C., Peruzzi, D., Ruthardt, M., Zelent, A., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/ng0298-126 · Cited by 557
Metadata
- Authors
- Grisolano, J. L., Wesselschmidt, R. L., Pelicci, P. G., & Ley, T. J.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1997-01-15
- Volume
- 89
- Issue
- 2
- Pages
- 376-387
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1579062391
- Cited by
- 352
- References
- 43
- FWCI
- 7.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.